Evaluation and Management Strategies for GI Involvement with Amyloidosis

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Amyloidosis is a heterogeneous disease that can cause a wide array of nonspecific symptoms when the gastrointestinal (GI) tract is involved, including weight loss, early satiety, change in bowel habits with diarrhea, constipation, or alternating bowel pattern. Endoscopy with biopsy for Congo red staining establishes the diagnosis and fibril subtyping helps to guide targeted treatment options. Light chain amyloidosis is the most frequent subtype found throughout the GI tract. Transthyretin amyloidosis is most likely to be found on rectal biopsy. Management of the symptoms of GI tract involvement with amyloidosis relate to addressing the underlying symptom complex that is produced and generally abstracted from the management of severe forms of functional GI disorders. Attention to improving symptom management and nutrition status can improve quality of life in these patients.

Original languageEnglish
Pages (from-to)S20-S23
JournalAmerican Journal of Medicine
StatePublished - Apr 2022


  • Amyloidosis
  • Gastrointestinal


Dive into the research topics of 'Evaluation and Management Strategies for GI Involvement with Amyloidosis'. Together they form a unique fingerprint.

Cite this